We are live on
!
Find out more
ECG
EPIQ Capital Group Portfolio holdings
AUM
$383M
1-Year Est. Return
46.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+46.87%
3 Year Est. Return
-6.25%
5 Year Est. Return
+38.91%
10 Year Est. Return
–
AUM
$699M
AUM Growth
+$105M
(+18%)
Cap. Flow
-$6.97M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
93.51%
Holding
48
New
4
Increased
18
Reduced
14
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quince Therapeutics
QNCX
|
+$3.27M |
| 2 |
Blue Owl Capital
OBDC
|
+$479K |
| 3 |
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
|
+$389K |
| 4 |
Peloton Interactive
PTON
|
+$181K |
| 5 |
Alector
ALEC
|
+$173K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$6.14M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$1.54M |
| 3 |
JD.com
JD
|
+$1.11M |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$912K |
| 5 |
Vir Biotechnology
VIR
|
+$411K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.31% |
| 2 | Miscellaneous | 27.86% |
| 3 | Consumer Discretionary | 5.82% |
| 4 | Communication Services | 1.34% |
| 5 | Technology | 0.3% |
Similar funds
BCA
SAM
GJCM
AP
FWM
BW
WWP
CIM
EPIQ Capital Group's Q3 2020 Portfolio in Review
As of Q3 2020, EPIQ Capital Group held 48 positions worth $699M, up 18% from $594M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
EPIQ Capital Group's Q3 2020 filing shows 4 new, 18 increased, 14 reduced and 3 closed positions. Its largest new stake was Blue Owl Capital: 39,095 shares worth $487K. The largest sale was Alibaba, an estimated $6.14M.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 63% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
- EPIQ Capital Group's largest Q3 2020 buy was Blue Owl Capital: 39,095 shares worth $487K.
- EPIQ Capital Group added most to Quince Therapeutics in Q3 2020, an estimated $3.27M increase.
- EPIQ Capital Group's biggest Q3 2020 reduction was Alibaba, cutting an estimated $6.14M.
- EPIQ Capital Group fully exited Vir Biotechnology in Q3 2020, selling an estimated $411K.
- EPIQ Capital Group's ten largest holdings make up 94% of its $699M portfolio in Q3 2020.
- EPIQ Capital Group opened 4 new positions and closed 3 in Q3 2020.
- EPIQ Capital Group's portfolio value rose 18% quarter-over-quarter to $699M.
Based on EPIQ Capital Group's 13F filing for Q3 2020, filed 6 Nov 2020.